IRS 954 (DV-1709) is a specific inhibitor of TLR7 and 9 that reduced serum levels of nucleic acid-specific antibodies, and reduced end-organ damage in a lupus murine model [142]. This evidence concerns the gene TLR7 and systemic lupus erythematosus.